Related Experiment Video

Updated: May 15, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Does plasma HDL-C concentration interact with whole-body cholesterol metabolism?

C C Leança1, V S Nunes, E R Nakandakare

  • 1Lipids Laboratory (LIM-10), Endocrinology and Metabolism Division of Hospital das Clinicas, Faculty of Medical Sciences, University of Sao Paulo, Av. Dr. Arnaldo 455, Room 3305, 01246-000 São Paulo, SP, Brazil.

Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|January 22, 2013
PubMed

Insights

Plasma high-density lipoprotein (HDL) influences cholesterol synthesis but not intestinal absorption. While cholesterol metabolism changes don't clearly affect HDL-C, HDL-C may control synthesis and absorption markers, especially in genetic conditions.

Area of Science:

  • Lipid Metabolism
  • Cardiovascular Health
  • Cholesterol Homeostasis

Background:

  • High-density lipoprotein cholesterol (HDL-C) plays a crucial role in reverse cholesterol transport.
  • Understanding the interplay between HDL metabolism and overall cholesterol economy is vital for cardiovascular health.
  • Existing research presents complex interactions between HDL and systemic cholesterol regulation.

Purpose of the Study:

  • To investigate the correlation between plasma HDL-C concentrations and whole-body cholesterol metabolism parameters.
  • To determine if alterations in cholesterol metabolism impact plasma HDL-C levels.
  • To ascertain whether plasma HDL specifically controls markers of cholesterol synthesis and intestinal absorption.

Main Methods:

  • Literature review and synthesis of existing research on HDL metabolism and cholesterol economy.
  • Analysis of studies addressing the relationship between HDL-C levels and cholesterol synthesis/absorption markers.
  • Examination of genetic and population-based data linking HDL-C to metabolic factors.

Main Results:

  • Plasma HDL positively influences whole-body cholesterol synthesis rates.
  • Current evidence does not strongly support HDL's role in modifying total intestinal cholesterol absorption.
  • Changes in whole-body cholesterol metabolism do not appear to interfere with plasma HDL-C concentrations.
  • Markers of cholesterol synthesis and absorption may be controlled by HDL-C, particularly in genetic disorders causing very low HDL-C.

Conclusions:

  • Plasma HDL significantly impacts cholesterol synthesis, but its effect on intestinal absorption remains unclear.
  • While systemic cholesterol metabolism changes may not directly affect HDL-C, HDL-C might regulate synthesis and absorption markers.
  • In the general population, low HDL-C is often linked to insulin resistance and diabetes mellitus, whereas genetic factors are implicated in extremely low HDL-C levels.

More Related Videos

High-Density Lipoprotein-Specific Phospholipid Efflux Assay07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Hepatic Drug Clearance: Effect of Protein Binding01:09

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...